Goodwill and Other Intangible Assets

3 Months Ended

Dec. 31, 2025

Goodwill and Intangible Assets Disclosure [Abstract]

In connection with the change in the Company's reporting structure described in Note 1, the Company reallocated goodwill from the U.S. Healthcare Solutions reportable segment to Other based on the reporting units that were transferred. The following is a summary of the changes in the carrying value of goodwill, by reportable segment, for the three months ended December 31, 2025:


(in thousands)	U. S. Healthcare Solutions		International Healthcare Solutions		Other		Total
Goodwill as of September 30, 2025	$	11,104,990	$	2,571,530	$	—	$	13,676,520
Reallocated goodwill	(1,421,428)		—		1,421,428		—
Goodwill recognized in connection with acquisitions	140,945		72,617		—		213,562
Purchase accounting adjustments	1,988		—		—		1,988
Goodwill impairment	—		—		(165,665)		(165,665)
Foreign currency translation	—		4,084		272		4,356
Goodwill as of December 31, 2025	$	9,826,495	$	2,648,231	$	1,256,035	$	13,730,761

The Company recorded a goodwill impairment of $165.7 million related to its U.S. Consulting Services business that was classified as held for sale as of December 31, 2025.

The following is a summary of other intangible assets:


	December 31, 2025							September 30, 2025
(in thousands)	Weighted Average Remaining Useful Life	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Indefinite-lived trade names		$	17,000	$	—	$	17,000	$	17,000	$	—	$	17,000
Finite-lived:
Customer relationships	12 years	5,232,445		(1,903,803)		3,328,642		5,250,912		(1,860,484)		3,390,428
Trade names and other	12 years	1,473,344		(1,140,259)		333,085		1,457,176		(1,090,423)		366,753
Total other intangible assets		$	6,722,789	$	(3,044,062)	$	3,678,727	$	6,725,088	$	(2,950,907)	$	3,774,181

Amortization expense for finite-lived intangible assets was $126.1 million and $165.8 million in the three months ended December 31, 2025 and 2024, respectively. Amortization expense for finite-lived intangible assets is estimated to be $399.8 million in fiscal 2026, $344.0 million in fiscal 2027, $332.2 million in fiscal 2028, $317.3 million in fiscal 2029, $296.0 million in fiscal 2030, and $2,098.5 million thereafter.

Cencora, Inc. 10-Q